{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:20:17Z","timestamp":1787325617964,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["AI154656"],"award-info":[{"award-number":["AI154656"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.virol.2025.110674","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:18:09Z","timestamp":1756768689000},"page":"110674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Interferon-\u03b3 receptor signaling is critical for balanced immune activation and protection against influenza after vaccination"],"prefix":"10.1016","volume":"612","author":[{"given":"Ki-Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Suk","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-331X","authenticated-orcid":false,"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110674_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110674_bib2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241148","article-title":"Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection","volume":"222","author":"Broomfield","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2025.110674_bib3","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1128\/JVI.07172-11","article-title":"Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection","volume":"86","author":"Brown Deborah","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110674_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fimmu.2018.00781","article-title":"Natural killer cell recruitment to the lung during influenza A virus infection is dependent on CXCR3, CCR5, and virus exposure dose","volume":"9","author":"Carlin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib5","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2015.06.047","article-title":"ISCOMATRIX adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans","volume":"33","author":"Chung","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2025.110674_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104703","article-title":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: potential effects on adaptive immunity and response to vaccination","volume":"174","author":"Clarke","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110674_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20151722","article-title":"IFN-\u03b3 receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity","volume":"213","author":"Domeier","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2025.110674_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4049\/jimmunol.2200407","article-title":"STAT1 controls the functionality of influenza-primed CD4 T cells but therapeutic STAT4 engagement Maximizes their antiviral impact","volume":"210","author":"Finn","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.1103474","article-title":"NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-\u03b3 and perforin-dependent mechanisms","volume":"189","author":"Ge","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/icb.2009.60","article-title":"The functional impairment of natural killer cells during influenza virus infection","volume":"87","author":"Guo","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2025.110674_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/ki.1995.470","article-title":"MHC antigens in interferon gamma (IFN gamma) receptor deficient mice: IFN gamma-dependent up-regulation of MHC class II in renal tubules","volume":"48","author":"Haas","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.virol.2025.110674_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2014.07.016","article-title":"Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis","volume":"110","author":"Hwang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110674_bib14","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110674_bib15","article-title":"BCG cell wall skeleton as a vaccine adjuvant protects both infant and old-aged mice from influenza virus infection","volume":"9","author":"Kim","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.virol.2025.110674_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010755","article-title":"Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2025.110674_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but No protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.virol.2025.110674_bib17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","article-title":"Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T cells and germinal centers","volume":"37","author":"Lee","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2025.110674_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.virol.2025.110674_bib19","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.vaccine.2011.07.099","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico","volume":"29","author":"Lopez-Macias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2025.110674_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.virol.2025.110674_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00824-16","article-title":"Gamma interferon-regulated chemokines in leishmania donovani infection in the liver","volume":"85","author":"Murray","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2025.110674_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2015.04.005","article-title":"Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection","volume":"17","author":"Ng","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2025.110674_bib24","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1073\/pnas.1220456110","article-title":"Interferon-\u03b3 mediates chemokine-dependent recruitment of natural killer cells during viral infection","volume":"110","author":"Pak-Wittel","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2025.110674_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib26","doi-asserted-by":"crossref","first-page":"S986","DOI":"10.1093\/infdis\/jir335","article-title":"Filovirus infection of STAT-1 knockout mice","volume":"204","author":"Raymond","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110674_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent ENDPOINTS12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2025.110674_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.virol.2025.110674_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103131","article-title":"Synergistic effect of non-neutralizing antibodies and interferon-\u03b3 for cross-protection against influenza","volume":"24","author":"Shibuya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.virol.2025.110674_bib31","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110674_bib32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.175.5.1367","article-title":"Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens","volume":"175","author":"Snapper","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2025.110674_bib33","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1021\/pr200086v","article-title":"Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity","volume":"10","author":"Song","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.virol.2025.110674_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.virol.2025.110674_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104702","article-title":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: vaccine efficacy studies","volume":"174","author":"Zivcec","year":"2020","journal-title":"Antivir. Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:36:41Z","timestamp":1780303001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225002880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"alternative-id":["S0042682225002880"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110674","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b3 receptor signaling is critical for balanced immune activation and protection against influenza after vaccination","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110674"}}